Antithrombin III human
USP/1040504 - 4.38 IU, United States Pharmacopeia (USP) Reference Standard
CAS Number: 9000-94-6
MDL Number: MFCD00166632
Product Type: Chemical
| application(s) | USP Biologics pharmaceutical (small molecule) |
| form | solid |
| format | neat |
| grade | pharmaceutical primary standard |
| manufacturer/tradename | USP |
| quality | 4.38 IU |
| storage temp. | −20°C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Disclaimer: | RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization. |
| General description: | Antithrombin III is a serine protease inhibitor present in human plasma that inactivates thrombin and other coagulation factors. It is used therapeutically in hereditary antithrombin deficiency. The USP reference standard supports potency and identity testing in plasma-derived and recombinant antithrombin products. The USP biologics proteins category provides critical standards and reference materials necessary for the development and manufacturing of therapeutic proteins. These proteins, which can be naturally derived or genetically engineered, are essential in treating various diseases and conditions, ensuring that they meet quality, safety, and efficacy standards. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of the USP Biologics program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia   . |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Storage Temp. | −20°C |
| UNSPSC | 41116107 |